ArticleInternational journal of clinical oncology2024

Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institution.

Yosuke Yasuda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.